Repare Therapeutics Inc
NASDAQ:RPTX

  • LAST PRICE
    3.2800
  • TODAY'S CHANGE (%)
    -0.0400 (-1.2048%)
  • Bid / Lots
    3.1500/ 3
  • Ask / Lots
    3.5500/ 1
  • Open / Previous Close
    3.3800 / 3.3200
  • Day Range
    3.2400
    3.3900
  • 52 Week Range
    2.7100
    8.4900
  • Volume
    96,511

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Nov 12, 2024

  • Nov 8, 2024

  • Nov 7, 2024

      Show headlines and story abstract

    • 7:05AM ET on Thursday Nov 07, 2024 by Dow Jones
      Companies Mentioned: RPTX
      Total operating expenses 36,372 40,577 116,352 123,443 ---------- ---------- ---------- ---------- Loss from operations (36,372) (38,418) (62,875) (85,357) ---------- ---------- ---------- ---------- Other income (expense), net Realized and unrealized (loss) gain on foreign exchange (19) (40) 18 (137) Interest income 2,512 3,312 8,374 10,228 Other expense (42) (32) (95) (73) ---------- ---------- ---------- ---------- Total other income, net 2,451 3,240 8,297 10,018 ---------- ---------- ---------- ---------- Loss before income taxes (33,921) (35,178) (54,578) (75,339) Income tax (expense) recovery (485) 16,299 (1,440) 9,573 ---------- ---------- ---------- ---------- Net loss $ (34,406) $ (18,879) $ (56,018) $ (65,766) ========== ========== ========== ========== Other comprehensive income: Unrealized gain on available-for-sale marketable securities $ 274 $ 172 $ 112 $ 176 ---------- ---------- ---------- ---------- Total other comprehensive income 274 172 112 176 ---------- ---------- ---------- ---------- Comprehensive loss $ (34,132) $ (18,707) $ (55,906) $ (65,590) ========== ========== ========== ========== Net loss per share attributable to common shareholders - basic and diluted $ (0.81) $ (0.45) $ (1.32) $ (1.56) Weighted-average common shares outstanding - basic and diluted 42,452,617 42,102,685 42,377,635 42,077,857

    • 7:05AM ET on Thursday Nov 07, 2024 by Dow Jones
      Companies Mentioned: RPTX
      Total operating expenses 36,372 40,577 116,352 123,443 ---------- ---------- ---------- ---------- Loss from operations (36,372) (38,418) (62,875) (85,357) ---------- ---------- ---------- ---------- Other income (expense), net Realized and unrealized (loss) gain on foreign exchange (19) (40) 18 (137) Interest income 2,512 3,312 8,374 10,228 Other expense (42) (32) (95) (73) ---------- ---------- ---------- ---------- Total other income, net 2,451 3,240 8,297 10,018 ---------- ---------- ---------- ---------- Loss before income taxes (33,921) (35,178) (54,578) (75,339) Income tax (expense) recovery (485) 16,299 (1,440) 9,573 ---------- ---------- ---------- ---------- Net loss $ (34,406) $ (18,879) $ (56,018) $ (65,766) ========== ========== ========== ========== Other comprehensive income: Unrealized gain on available-for-sale marketable securities $ 274 $ 172 $ 112 $ 176 ---------- ---------- ---------- ---------- Total other comprehensive income 274 172 112 176 ---------- ---------- ---------- ---------- Comprehensive loss $ (34,132) $ (18,707) $ (55,906) $ (65,590) ========== ========== ========== ========== Net loss per share attributable to common shareholders - basic and diluted $ (0.81) $ (0.45) $ (1.32) $ (1.56) Weighted-average common shares outstanding - basic and diluted 42,452,617 42,102,685 42,377,635 42,077,857

Peers Headlines